ABSTRACT
Preliminary clinical trials suggest that therapeutic hypothermia might improve the outcomes of patients with acute stroke. Definitive trials are under way.
Footnotes
↵* The author has indicated that he has received grant or research support from Radiant Medical Inc, is a consultant for Medcool, Inc, and is on the speakers’ bureaus of Sanofi-Synthelabo and the Bristol-Myers Squibb Company. This paper discusses treatment that is not approved by the US Food and Drug Administration for the use under discussion.
- Copyright © 2002 The Cleveland Clinic Foundation. All Rights Reserved.